Tags: clinical trial + fingolimod.with.MS

Sort by: Date / Title / URL

1. My free online diary - Glitterbabe
   A diary from a participant in the Avonex-Fingolimod clinical trial
   08-07-2007 to avonex, clinical trial, fingolimod, multiple sclerosis, people by admin
2. Preclinical Studies Suggest FTY720 Mechanisms In Multiple Sclerosis May Include Direct Activity In The Brain
   The data suggest that FTY720 may have the potential to reduce neurodegeneration and enhance repair of the central nervous system (CNS) by modulating S1P receptors expressed on brain cells.
   06-05-2007 to clinical trial, depression, drugs, fingolimod, multiple sclerosis, study by admin
3. Roskamp Institute Looking for Volunteers for Multiple Sclerosis Research Study
   The Roskamp Institute announced today its participation in a pharmaceutical sponsored research study for relapsing-remitting Multiple Sclerosis (MS) sufferers.
   08-12-2006 to clinical trial, drug company, drugs, fingolimod, multiple sclerosis, relapsing remitting, research, rrms, study by admin
4. New data for FTY720 - aiming to become the first orally effective multiple sclerosis treatment - show sustained benefits over two years
   The developmental oral therapy FTY720 (fingolimod) has demonstrated sustained benefits over two years in patients suffering from relapsing multiple sclerosis (MS), indicating that it could provide an important new option for treating this disabling neurol
   29-09-2006 to clinical trial, drugs, fingolimod, multiple sclerosis, research, study, treatment by admin
5. Clinical Trial: Extension Study to Evaluate Safety, Tolerability and Effects on Efficacy Parameters of FTY720 in Patients With Relapsing Multiple Sclerosis.
   This study will evaluate the long-term safety, tolerability and effect on MRI lesion parameters of FTY720 in patients with relapsing multiple sclerosis.
   14-09-2006 to clinical trial, drugs, fingolimod, multiple sclerosis, relapsing remitting, research, rrms, study by admin
6. NEJM -- Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
   In this proof-of-concept study, fingolimod reduced the number of lesions detected on MRI and clinical disease activity in patients with multiple sclerosis. Evaluation in larger, longer-term studies is warranted.
   14-09-2006 to clinical trial, drugs, fingolimod, multiple sclerosis, research, study, treatment by admin

First / Previous / Next / Last / Page 1 of 1